Compare CHPT & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHPT | LNSR |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.2M | 146.7M |
| IPO Year | 2019 | 2005 |
| Metric | CHPT | LNSR |
|---|---|---|
| Price | $6.27 | $5.66 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $9.25 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 478.0K | 67.2K |
| Earning Date | 06-03-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $411,224,000.00 | $58,435,000.00 |
| Revenue This Year | $4.18 | $10.06 |
| Revenue Next Year | $16.63 | $41.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $0.58 | $5.06 |
| 52 Week High | $12.62 | $13.74 |
| Indicator | CHPT | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 52.28 | 45.77 |
| Support Level | $5.60 | $5.25 |
| Resistance Level | $6.73 | $6.39 |
| Average True Range (ATR) | 0.33 | 0.33 |
| MACD | -0.07 | 0.15 |
| Stochastic Oscillator | 18.11 | 68.67 |
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable charging systems owners, charge point operators, to manage their Networked Charging Systems, and to enable drivers to locate, reserve and authenticate Networked Charging Systems and to transact EV charging sessions on those systems. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. The company derives the majority of its revenue from the United States.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.